The Aortic Valve DECalcification (AVADEC) Trial
clinical trial
Press Enter · cited answer in seconds
0 sources
Summary
The Aortic Valve DECalcification (AVADEC) Trial is a clinical trial[1].
Key Facts
- The Aortic Valve DECalcification (AVADEC) Trial is in the country of Denmark[2].
- The Aortic Valve DECalcification (AVADEC) Trial's instance of is recorded as clinical trial[3].
- The Aortic Valve DECalcification (AVADEC) Trial's start time is recorded as +2018-01-12T00:00:00Z[4].
- The Aortic Valve DECalcification (AVADEC) Trial's end time is recorded as +2020-12-31T00:00:00Z[5].
- The Aortic Valve DECalcification (AVADEC) Trial's main subject is recorded as aortic valve stenosis[6].
- The Aortic Valve DECalcification (AVADEC) Trial's number of participants is recorded as {'unit': '1', 'amount': '+400'}[7].
- The Aortic Valve DECalcification (AVADEC) Trial's title is recorded as The Effects of Menaquinone-7 Supplementation in Patients With Aortic Valves Calcification[8].
- The Aortic Valve DECalcification (AVADEC) Trial's short name is recorded as AVADEC[9].
- The Aortic Valve DECalcification (AVADEC) Trial's minimum age is recorded as {'unit': 'http://www.wikidata.org/entity/Q577', 'amount': '+65'}[10].
- The Aortic Valve DECalcification (AVADEC) Trial's ClinicalTrials.gov ID is recorded as NCT03243890[11].
- The Aortic Valve DECalcification (AVADEC) Trial's maximum age is recorded as {'unit': 'http://www.wikidata.org/entity/Q577', 'amount': '+75'}[12].
- The Aortic Valve DECalcification (AVADEC) Trial's research intervention is recorded as (5R)-24,25-Dihydroxyvitamin D[13].
- The Aortic Valve DECalcification (AVADEC) Trial's research intervention is recorded as (E)-phytonadione[14].
- The Aortic Valve DECalcification (AVADEC) Trial's clinical trial phase is recorded as phase I clinical trial[15].
- The Aortic Valve DECalcification (AVADEC) Trial's research site is recorded as Odense University[16].
- The Aortic Valve DECalcification (AVADEC) Trial's study type is recorded as interventional study[17].